Enantioselective Pharmacokinetics of Venlafaxine in the Presence of CYP2D6 Inhibition: A Population Parent-Metabolite Modeling Approach.

Saved in:
Bibliographic Details
Title: Enantioselective Pharmacokinetics of Venlafaxine in the Presence of CYP2D6 Inhibition: A Population Parent-Metabolite Modeling Approach.
Authors: Alves BCM; Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Bahia, Salvador, Brazil., Yamamoto PA; Department of Pharmaceutics, Center for Pharmacometrics & Systems Pharmacology, University of Florida, Orlando, FL, USA., Souza CDS; School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil., Lanchote VL; School of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Ribeirão Preto, Brazil., Rocha A; School of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Ribeirão Preto, Brazil., de Moraes NV; Department of Pharmaceutics, Center for Pharmacometrics & Systems Pharmacology, University of Florida, Orlando, FL, USA., Godoy ALPC; Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Bahia, Salvador, Brazil.
Source: Journal of clinical pharmacology [J Clin Pharmacol] 2026 Apr; Vol. 66 (4), pp. e70194.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1552-4604
DOI:10.1002/jcph.70194